Anaphylaxis Industry Pipeline Review H2 2016 - Orbis Research

Anaphylaxis-Pipeline Review, H2 2016

www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019

Description Anaphylaxis is a severe, potentially life-threatening allergic reaction. Anaphylaxis symptoms include dizziness, nausea, vomiting or diarrhea, feeling of warmth, constriction of the airways and a swollen tongue or throat. Risk factors include personal history of anaphylaxis, allergies or asthma and family history. Treatment includes beta-agonist, antihistamines and cortisone.

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/148556 .

Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Anaphylaxis – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Anaphylaxis (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Anaphylaxis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Anaphylaxis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Filing rejected/Withdrawn and Preclinical stages are 1 and 4 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.Anaphylaxis.

Anaphylaxis (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/148556 .

For more information contact sales@orbisresearch.com Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Anaphylaxis (Immunology).

- The pipeline guide reviews pipeline therapeutics for Anaphylaxis (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from preregistration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product

www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019

description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Anaphylaxis (Immunology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Anaphylaxis (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Anaphylaxis (Immunology) Browse Complete Report @ http://www.orbisresearch.com/reports/index/anaphylaxis-pipelinereview-h2-2016 .

List of Figures Number of Products under Development for Anaphylaxis, H2 2016 7 Number of Products under Development for Anaphylaxis - Comparative Analysis, H2 2016 8 Number of Products under Development by Companies, H2 2016 9 Comparative Analysis by Early Stage Products, H2 2016 12 Assessment by Monotherapy Products, H2 2016 18 Number of Products by Targets, H2 2016 19 Number of Products by Stage and Targets, H2 2016 19 Number of Products by Mechanism of Actions, H2 2016 21 Number of Products by Stage and Mechanism of Actions, H2 2016 21 Number of Products by Routes of Administration, H2 2016 23 Number of Products by Stage and Routes of Administration, H2 2016 23 Number of Products by Molecule Types, H2 2016 25 Number of Products by Stage and Molecule Types, H2 2016 25 For any enquires before buying, connect with us @ enquiry@orbisresearch.com About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information: Hector Costello Senior Manager – Client Engagements 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.

www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019

Phone No.: +1 (214) 884-6817; +9164101019 Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research Follow us on Twitter: https://twitter.com/orbisresearch Like us on Facebook: https://www.facebook.com/OrbisResearch

www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019